Stock listing
Hightide Therapeutics Inc
Selected listing: 2511 · HKEX · HKD · HK
Hightide Therapeutics Inc (HKEX:2511), Health Technology. Latest release Oct 2, 2026: Monthly Return of Equity Issuer on Movements in Securities for the month…
- Ticker
- HKEX:2511
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Hightide Therapeutics Inc
Hightide Therapeutics Inc is a public company listed on the Hong Kong market under the ticker 2511. Hightide Therapeutics focuses on developing innovative therapeutic solutions.
Latest news from Hightide Therapeutics Inc
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
2026 Interim Report
September 29, 2026
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate...
June 7, 2024
Research Hightide Therapeutics Inc
Hightide Therapeutics Inc company profile
View the public company page for Hightide Therapeutics Inc on 6ix.
Hightide Therapeutics Inc news
Read company news and market updates connected to Hightide Therapeutics Inc.
Hightide Therapeutics Inc investor events
Find investor webinars, events, and replay context for Hightide Therapeutics Inc.